ALSO NOTED: Allergy says it's on track to launch vaccine; Depomed starts dosing; and much more...

> Allergy Therapeutics says it's on track to launch a hayfever vaccine by 2009. Report

> Depomed has begun dosing patients in a Phase II trial of Gabapentin GR for menopausal hot flashes, sending its stock up in early trading. Report

> Simcere Pharmaceutical Group has entered into an agreement to acquire an additional 10 percent equity interest in Shandong Simcere Medgenn Bio-Pharmaceutical. Release

> WHO says it is advancing plans for a global stockpile of H5N1 flu vaccine. Report

And Finally... Medical centers specializing in cancer care say that health plans are denying coverage for routine care to patients who have enrolled in clinical trials. And now, they're backing a new bill which would make this practice illegal. Report

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.